ACE and Stroke: Patients with sPAP  ≥ 40mmHg had lower BMI (23.6 ± 3.7 vs. 25.4 ± 3.8 kg/m2) and were less frequently treated with calcium channel blocker (21.2% vs. 39.1%) compared to patients with a sPAP < 40mmHg.There were no significant differences between the two groups in gender, previous stroke or in number of patients treated with PCI, betablockers, angiotensin converting enzyme inhibitors/angiotensin receptor blockers, diuretics, statins, or digoxin.